Immuneering Corp. (IMRX)
6.665
-0.06
(-0.97%)
USD |
NASDAQ |
Dec 29, 16:00
6.51
-0.16
(-2.33%)
After-Hours: 20:00
Immuneering Market Cap: 430.36M for Dec. 29, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 52.69B |
| Regeneron Pharmaceuticals, Inc. | 82.03B |
| Fortress Biotech, Inc. | 111.12M |
| BridgeBio Pharma, Inc. | 14.57B |
| Absci Corp. | 518.03M |
Market Cap Related Metrics
| Price to Book Value | 1.888 |
| Price | 6.665 |
| Earnings Yield | -26.75% |